Stay updated on CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The updates appear to be administrative in nature, including revised last update dates and minor formatting/text edits; no changes to the core trial content (arms, eligibility, or outcomes) were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:18:26.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.
    Difference
    2%
    Check dated 2025-10-06T04:15:58.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Term naming updated from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' with a version bump to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T23:42:12.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page updates to Revision: v3.0.2, replacing v3.0.1, signaling a patch release. The Back to Top navigation element has been removed, a small UI/navigation change.
    Difference
    0.1%
    Check dated 2025-09-14T09:52:07.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-07T07:50:21.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information for Durvalumab and Tremelimumab. However, several previous entries related to drug information and genetic disease resources have been removed.
    Difference
    2%
    Check dated 2025-08-31T01:00:09.000Z thumbnail image

Stay in the know with updates to CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.